Dr. Joyson Poulose
Claim this profileGuthrie Medical Group PC-Robert Packer Hospital
Studies Cancer
Studies Lung Cancer
25 reported clinical trials
66 drugs studied
About Joyson Poulose
Education:
- Earned an Associate in Applied Science (A.A.S.) degree in Respiratory Therapy from Guthrie Robert Packer Hospital, Sayre, PA.
Experience:
- Serves as a Clinical Instructor in Respiratory Therapy at Guthrie Robert Packer Hospital, Sayre, PA.
Area of expertise
1Cancer
Stage IV
HER2 positive
Stage III
2Lung Cancer
Stage IV
Stage III
EGFR negative
Affiliated Hospitals
Clinical Trials Joyson Poulose is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
More about Joyson Poulose
Clinical Trial Related5 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Joyson Poulose has experience with
- Pembrolizumab
- Fluorouracil
- Nivolumab
- Carboplatin
- Biospecimen Collection
- Leucovorin Calcium
Breakdown of trials Joyson Poulose has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joyson Poulose specialize in?
Joyson Poulose focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Joyson Poulose currently recruiting for clinical trials?
Yes, Joyson Poulose is currently recruiting for 15 clinical trials in Sayre Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Joyson Poulose has studied deeply?
Yes, Joyson Poulose has studied treatments such as Pembrolizumab, Fluorouracil, Nivolumab.
What is the best way to schedule an appointment with Joyson Poulose?
Apply for one of the trials that Joyson Poulose is conducting.
What is the office address of Joyson Poulose?
The office of Joyson Poulose is located at: Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania 18840 United States. This is the address for their practice at the Guthrie Medical Group PC-Robert Packer Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.